Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-06

Clinical Trial Update: The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B) [Phase 1, Phase 2]

View source ↗

Summary

The trial update reports on the safety and tolerability of SerpinPC in healthy men and in men with Hemophilia A or B across Phase 1 and Phase 2, with the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SerpinPC

Snippet

Sponsor: ApcinteX Ltd | Conditions: Hemophilia a, Hemophilia B | Phase 1, Phase 2 | Status: COMPLETED